PHMMF (Pharma Mar) Market Cap : $1,376.0 Mil (As of Dec. 11, 2024)

View and export this data going back to 2009. Start your Free Trial

What is Pharma Mar Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Pharma Mar's share price for the quarter that ended in Sep. 2024 was $54. Pharma Mar's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 17.4 Mil. Therefore, Pharma Mar's market cap for the quarter that ended in Sep. 2024 was $938.3 Mil.

Pharma Mar's quarterly market cap increased from Mar. 2024 ($512.8 Mil) to Jun. 2024 ($617.8 Mil) and increased from Jun. 2024 ($617.8 Mil) to Sep. 2024 ($938.3 Mil).

Pharma Mar's annual market cap increased from Dec. 2021 ($1,125.7 Mil) to Dec. 2022 ($1,256.4 Mil) but then declined from Dec. 2022 ($1,256.4 Mil) to Dec. 2023 ($816.0 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Pharma Mar's Enterprise Value for Today is $1,334.2 Mil.

Pharma Mar Market Cap Historical Data

The historical data trend for Pharma Mar's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Market Cap Chart

Pharma Mar Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

876.73

1,581.24

1,125.66

1,256.43

816.02

Pharma Mar Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Market Cap	Get a 7-Day Free Trial															593.22	816.02	512.81	617.81	938.26

Competitive Comparison of Pharma Mar's Market Cap

For the Biotechnology subindustry, Pharma Mar's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma Mar's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's Market Cap distribution charts can be found below:

* The bar in red indicates where Pharma Mar's Market Cap falls into.

Pharma Mar Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Pharma Mar's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	$46.26	*	17.6399
	=	$816.0

Pharma Mar's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )	=	Share Price (Q: Sep. 2024 )	*	Shares Outstanding (EOP) (Q: Sep. 2024 )
	=	$54	*	17.3752
	=	$938.3

Pharma Mar (OTCPK:PHMMF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Pharma Mar Market Cap Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Mar Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (OTCPK:PHMMF) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

PHMe:UK 0RC6:UK PHM:Spain

Address

Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770

Website

http://www.pharmamar.com

Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.